£325.00

It has never been this cheap. We have no record of a lower price.

£325 today · cheaper than every other day in the last 3 months

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 29 days · 29 data points (no recent data)

Historical
Generating forecast…
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 25 July 2026 01 August 2026 08 August 2026 15 August 2026 22 August 2026
View at Amazon ↗

Price data last checked 62 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price
29 days 0 7 15 22 29 £325 Days at Price

Price Analysis

Most common price: £325 (29 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 29 days

Description
This econometric study covers the outlook for pancreatic cancer drugs in Africa & the Middle East. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries in Africa & the Middle East). This study gives, however, my estimates for the latent demand, or the P.I.E. for pancreatic cancer drugs in Africa & the Middle East. It also shows how the P.I.E. is divided across the national markets of Africa & the Middle East. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Product Specifications
Format
paperback
ASIN
B00E4CHBX4
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
24 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America
99% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America

£325.00 26 Aug 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe
99% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe

£325.00 21 Aug 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean
99% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean

£325.00 25 Aug 2026
The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East
99% match

The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East

£325.00 26 Aug 2026
The 2011-2016 Outlook for Pancreatic Cancer Drugs in Africa
99% match

The 2011-2016 Outlook for Pancreatic Cancer Drugs in Africa

£325.00 26 Aug 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
99% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana

£325.00 25 Aug 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
98% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 22 Aug 2026
The 2021-2026 World Outlook for Pancreatic Cancer Drugs
98% match

The 2021-2026 World Outlook for Pancreatic Cancer Drugs

£795.00 19 Aug 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 29 Aug 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China

£495.00 02 Sep 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in India
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in India

£515.00 11 Aug 2026
Pancreatic Cancer: Insights into Molecular Mechanisms and Novel Approaches to Early Detection and Treatment
97% match

Pancreatic Cancer: Insights into Molecular Mechanisms and Novel Approaches to Early Detection and Treatment

Price unavailable
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
97% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 26 Sep 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics for US Zip Codes

£490.00 11 Aug 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan

£495.00 14 Aug 2026
Understanding Pancreatic Cancer: Global Strategies and African Perspectives
97% match

Understanding Pancreatic Cancer: Global Strategies and African Perspectives

CRC Press

£80.59 22 Sep 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
96% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 11 Aug 2026
Pancreatic Cancer: Basic Mechanisms and Therapies (Volume 159) (Advances in Cancer Research, Volume 159)
96% match

Pancreatic Cancer: Basic Mechanisms and Therapies (Volume 159) (Advances in Cancer Research, Volume 159)

Elsevier

£117.99 10 Sep 2026
Pancreatic Cancer: Current Therapeutics and Future Directions
96% match

Pancreatic Cancer: Current Therapeutics and Future Directions

Springer

£88.21 24 Sep 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
96% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
IntechOpen Pancreatic Cancer - Clinical Management Book
96% match

IntechOpen Pancreatic Cancer - Clinical Management Book

IntechOpen

£139.00 13 Oct 2026
Current and Emerging Therapies in Pancreatic Cancer
96% match

Current and Emerging Therapies in Pancreatic Cancer

Springer

£89.30 30 Sep 2026
Pancreatic Cancer: A Multidisciplinary Approach
96% match

Pancreatic Cancer: A Multidisciplinary Approach

Springer

£156.60 02 Oct 2026
Pancreatic Cancer: A Multidisciplinary Approach - Springer
96% match

Pancreatic Cancer: A Multidisciplinary Approach - Springer

Springer

£111.89 02 Oct 2026